• Explore /
  • Poster
  • / Prognostic effect of <em>RAS/BRAF</em> mutations in patients (pts) with metastatic colorectal cancer (mCRC).

Prognostic effect of RAS/BRAF mutations in patients (pts) with metastatic colorectal cancer (mCRC).

Abstract Poster

Authors

Haisam Abid

Haisam Abid

Medical College of Wisconsin, Milwaukee, WI

Haisam Abid , Aniko Szabo , Bradley W. Taylor , Aditya V. Shreenivas , Sakti Chakrabarti , Mandana Kamgar , James P. Thomas , Ben George

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

DOI

10.1200/JCO.2022.40.4_suppl.191

Abstract #

191

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

Poster

2020 ASCO Virtual Scientific Program

Prognostic effect of specific <em>RAS/BRAF</em> mutations in patients (pts) with metastatic colorectal cancer (mCRC).

Prognostic effect of specific RAS/BRAF mutations in patients (pts) with metastatic colorectal cancer (mCRC).

First Author: Ben George

First Author: Deng Wei

First Author: Federico Innocenti

First Author: Yucai Wang